menu
    • menu

    Company profile for Biomarck Pharmaceuticals

    NEW Drugs in Dev: 1
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biomarck is a biopharmaceutical company with a patented technology platform. We utilize anti-MARCKS peptides in order to develop and license products targeted at difficult to treat diseases with unmet needs. We are located in Research Triangle Park, N.C.. Our company has a worldwide patented drug platform of over 100 peptides that inhibit the phosphorylation of the MARCKS protein, a well published primary mediator of an inf...
    Biomarck is a biopharmaceutical company with a patented technology platform. We utilize anti-MARCKS peptides in order to develop and license products targeted at difficult to treat diseases with unmet needs. We are located in Research Triangle Park, N.C.. Our company has a worldwide patented drug platform of over 100 peptides that inhibit the phosphorylation of the MARCKS protein, a well published primary mediator of an inflammatory cytokine release involved in respiratory disease and cancer progression.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biomarck PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2530 Meridian Parkway Suite 300 Durham, NC 27713
    Telephone
    Telephone
    + 1 646-866-4012
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biomarck.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Results of Biomarck Clinical and Preclinical Studies of BIO-11006
    Results of Biomarck Clinical and Preclinical Studies of BIO-11006

    07 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210707005086/en

    BUSINESSWIRE
    07 Jul 2021
    Share Share
    Results of Biomarck Phase II Study of BIO-11006 in Patients with ARDS
    Results of Biomarck Phase II Study of BIO-11006 in Patients with ARDS

    12 May 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210512005299/en

    BUSINESSWIRE
    12 May 2021
    Share Share
    Biomarck’s MARCKS Inhibitors for Uveitis to be at the 2021 Annual Meeting
    Biomarck’s MARCKS Inhibitors for Uveitis to be at the 2021 Annual Meeting

    27 Apr 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210427005333/en

    BUSINESSWIRE
    27 Apr 2021
    Share Share
    Biomarck presents at H.C. Wainwright 2021 Global Life Sciences Conference
    Biomarck presents at H.C. Wainwright 2021 Global Life Sciences Conference

    08 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210308005237/en

    BUSINESSWIRE
    08 Mar 2021
    Share Share
    Biomarck to Present Expanded Analysis of BIO-11006 Clinical Data in Treatment
    Biomarck to Present Expanded Analysis of BIO-11006 Clinical Data in Treatment

    01 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200601005454/en

    BUSINESSWIRE
    01 Jun 2020
    Share Share
    Biomarck Pharma to Present Expanded Analysis of BIO-11006 Clinical Data
    Biomarck Pharma to Present Expanded Analysis of BIO-11006 Clinical Data

    01 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200601005454/en/Biomarck-Pharmaceuticals-Present-Expanded-Analysis-BIO-11006-Clinical

    BUSINESSWIRE
    01 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search